NBI6024: Clinical Trials

1 trial of NBI6024, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow NBI6024: new trials by email Literature Review of NBI6024 trials Research Report on NBI6024

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate NBI-6024 in Adult and Adolescent Patients With New Onset of Type 1 Diabetes Mellitus
NBI-6024 - Type 1 Diabetes Mellitus
Phase 1CompletedNeurocrine Biosciences1882001-12-012009-04-01

Conditions studied

Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 1 (1)

Sponsors

Neurocrine Biosciences (1)

Countries

Canada (1)  ·  Czechia (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  South Africa (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Areti Philotheou, MD (1)

Results publications

PMID 19690081